{
  "trial_id": "NCT00191646",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, ethnicity, stage of cancer, histologic subtype, performance status, surgical outcome, time since surgery, baseline CA-125 levels, baseline hemoglobin levels, baseline white blood cell count, baseline platelet count, baseline creatinine levels, baseline liver function tests, prior medical history, concomitant medications.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Organ of Origin",
          "histologic subtype"
        ],
        [
          "Extent of Residual Disease",
          "surgical outcome"
        ],
        [
          "Zubrod Performance Status",
          "performance status"
        ],
        [
          "International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery",
          "stage of cancer"
        ],
        [
          "Histology",
          "histologic subtype"
        ],
        [
          "Volume of Residual Tumor Following Debulking Surgery",
          "surgical outcome"
        ],
        [
          "CA-125 Units per milliliter at Baseline for All Patients",
          "baseline CA-125 levels"
        ]
      ],
      "remaining_reference_features": [
        "Male"
      ],
      "remaining_candidate_features": [
        "Age",
        "ethnicity",
        "time since surgery",
        "baseline hemoglobin levels",
        "baseline white blood cell count",
        "baseline platelet count",
        "baseline creatinine levels",
        "baseline liver function tests",
        "prior medical history",
        "concomitant medications"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, stage of cancer, histologic subtype, performance status, surgical outcome, time since surgery, baseline CA-125 levels, baseline hemoglobin levels, baseline white blood cell count, baseline platelet count, baseline creatinine levels, baseline liver function tests, prior medical history, concomitant medications."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, Cancer Stage, Histologic Subtype, Performance Status, Baseline CA-125 Levels, Prior Surgery Details,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Organ of Origin",
          "Prior Surgery Details"
        ],
        [
          "Histology",
          "Histologic Subtype"
        ],
        [
          "Performance Status",
          "Performance Status"
        ],
        [
          "CA-125 Units per milliliter at Baseline for All Patients",
          "Baseline CA-125 Levels"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Extent of Residual Disease",
        "Zubrod Performance Status",
        "International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery",
        "Volume of Residual Tumor Following Debulking Surgery"
      ],
      "remaining_candidate_features": [
        "Age",
        "Region of Enrollment",
        "Cancer Stage"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, Region of Enrollment, Cancer Stage, Histologic Subtype, Performance Status, Baseline CA-125 Levels, Prior Surgery Details"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Histologic diagnosis, Stage of disease, Performance status, Prior surgery, Time from surgery to enrollment,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Histology",
          "Histologic diagnosis"
        ],
        [
          "International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery",
          "Stage of disease"
        ],
        [
          "Organ of Origin",
          "Prior surgery"
        ],
        [
          "Extent of Residual Disease",
          "Volume of Residual Tumor Following Debulking Surgery"
        ],
        [
          "Zubrod Performance Status",
          "Performance status"
        ],
        [
          "Time from surgery to enrollment",
          "Time from surgery to enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Race/Ethnicity",
        "CA-125 Units per milliliter at Baseline for All Patients"
      ],
      "remaining_candidate_features": [
        "Age"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Histologic diagnosis, Stage of disease, Performance status, Prior surgery, Time from surgery to enrollment"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, race, ethnicity, performance status, histologic diagnosis, tumor stage, tumor grade, presence of residual disease, surgical outcome, menopausal status, prior hormone replacement therapy, prior abdominal or pelvic radiotherapy, prior malignancies, comorbidities.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "menopausal status"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Race/Ethnicity",
          "ethnicity"
        ],
        [
          "Organ of Origin",
          "histologic diagnosis"
        ],
        [
          "Extent of Residual Disease",
          "presence of residual disease"
        ],
        [
          "Zubrod Performance Status",
          "performance status"
        ],
        [
          "International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery",
          "tumor stage"
        ],
        [
          "Histology",
          "histologic diagnosis"
        ],
        [
          "Volume of Residual Tumor Following Debulking Surgery",
          "surgical outcome"
        ]
      ],
      "remaining_reference_features": [
        "CA-125 Units per milliliter at Baseline for All Patients",
        "Male"
      ],
      "remaining_candidate_features": [
        "Age",
        "tumor grade",
        "prior hormone replacement therapy",
        "prior abdominal or pelvic radiotherapy",
        "prior malignancies",
        "comorbidities"
      ]
    },
    "processed-gen-response": "Age, race, ethnicity, performance status, histologic diagnosis, tumor stage, tumor grade, presence of residual disease, surgical outcome, menopausal status, prior hormone replacement therapy, prior abdominal or pelvic radiotherapy, prior malignancies, comorbidities."
  }
}